Number of Shares
28,278.00
Current Holdings Value*
$3.23 Mil
% of Portfolio
0.37%
Total Estimate Gain
$1.79 Mil
% of Total Estimate Gain
253.40%

MetLife Russell 2000 Index Portfolio's Corcept Therapeutics Inc Holding Summary

As of 2025-03-31, Brighthouse Funds Trust II held 28,278.00 shares of Corcept Therapeutics Inc(CORT), totaling $3.23 Mil. This investment constitutes 0.37% of their stock portfolio, and Brighthouse Funds Trust II now holds 0.03% of the outstanding Corcept Therapeutics Inc(CORT) stock.

The initial trade took place in 2019Q3. And since then MetLife Russell 2000 Index Portfolio has made 2 purchases of CORT, at an average price of $15.05, for a total of 47,054.00 shares. In addition, there have been 6 sales at an average price of $23.53 for 18,776.00 shares. Based on historical transaction data and CORT's current price of $72.85, MetLife Russell 2000 Index Portfolio's estimated gain on his CORT holdings is $1.79 Mil, reflecting a 253.40% gain to date.

MetLife Russell 2000 Index Portfolio CORT ($72.85) Holding Chart

MetLife Russell 2000 Index Portfolio CORT ($72.85) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1